Title | Frontline flumatinib versus imatinib in patients with chronic myeloid leukemia in chronic phase: Results from the China randomized phase III study. |
Authors | Li, Zhang Meng, Li Zhang, Yanli Zhu, Huanling Cui, Jiuwei Sun, Aining Hu, Yu Jin, Jie Jiang, Hao Zhang, Xi Li, Yan Liu, Qifa Liu, Li Zhang, Wanggang Gu, Jian Qiao, Jian-Hui Liu, Bingcheng Zhang, Fengkui Guo, Yong Wang, Jianxiang |
Affiliation | Chinese Acad Med Sci, Inst Hematol, State Key Lab Expt Hematol, Tianjin, Peoples R China Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Wuhan, Hubei, Peoples R China Henan Canc Hosp, Zhengzhou, Henan, Peoples R China Sichuan Univ, West China Hosp, Chengdu, Sichuan, Peoples R China Jinlin Univ, Hosp 1, Changchun, Jilin, Peoples R China Soochow Univ, Affiliated Hosp 1, Jiangsu Inst Hematol, Suzhou, Peoples R China Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Wuhan, Hubei, Peoples R China Zhe Jiang Med Univ, Hosp Affiliated 1, Hangzhou, Zhejiang, Peoples R China Peking Univ, Peoples Hosp, Inst Hematol, Beijing, Peoples R China Army Med Univ, Affiliated Hosp 2, Chongqing, Peoples R China China Med Univ, Hosp 1, Shenyang, Liaoning, Peoples R China Southern Med Univ, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China Fourth Mil Med Univ, Tangdu Hosp, Xian, Shaanxi, Peoples R China Xi An Jiao Tong Univ, Affiliated Hosp 2, Xian, Shaanxi, Peoples R China Northern Jiangsu Peoples Hosp, Yangzhou, Jiangsu, Peoples R China Peoples Liberat Army Gen Hosp, Med Ctr 5, Beijing, Peoples R China Jiangsu Hansoh Pharmaceut, Lianyuangang, Jiangsu, Peoples R China |
Issue Date | 2019 |
Publisher | JOURNAL OF CLINICAL ONCOLOGY |
URI | http://hdl.handle.net/20.500.11897/544024 |
ISSN | 0732-183X |
Indexed | CPCI-S(ISTP) SCI(E) |
Appears in Collections: | 人民医院 |